Search

everythinglearnresearchcommunity

for

Search:↓

Some patients on Baricitinib for alopecia areata lost response, often linked to longer and more severe initial conditions.

JAK inhibitors can help treat alopecia areata but have risks and high costs.

Older age, pre-existing skin conditions, cirrhosis, and pegylated interferon use increase the risk of skin issues during hepatitis C treatment.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.

Ocrelizumab may cause pancreatitis in some patients.

Baricitinib is effective and safe for treating alopecia areata.

Baricitinib effectively regrows hair in severe alopecia areata cases.

Baricitinib helped regrow hair in patients with severe alopecia areata after other treatments failed.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Baricitinib helped some patients with tough-to-treat hair loss regrow hair, but more research is needed on its safety.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.

ADCs can effectively treat breast cancer but may cause side effects like nausea and hair loss.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

Some patients treated with peginterferon and ribavirin for chronic hepatitis C had mild to moderate skin reactions, but treatment did not need to be stopped.

A woman with rheumatoid arthritis lost all her hair during adalimumab treatment, and stopping the drug didn't help.

Combining UVB irradiation and anti-CD154 antibody improves hair follicle transplant survival.

JAK inhibitors are effective for long-term management of alopecia areata.

Baricitinib may effectively treat sudden hair whitening and regrowth in some cases.

Continued baricitinib treatment leads to significant scalp hair regrowth in severe alopecia areata patients.

34% of patients on hepatitis C treatment had reversible skin issues.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.